Abstract

The ability of the zebrafish heart to regenerate following injury makes it a valuable model to deduce why this capability in mammals is limited to early neonatal stages. Although metabolic reprogramming and glycosylation remodeling have emerged as key aspects in many biological processes, how they may trigger a cardiac regenerative response in zebrafish is still a crucial question. Here, by using an up-to-date panel of transcriptomic, proteomic and glycomic approaches, we identify a metabolic switch from mitochondrial oxidative phosphorylation to glycolysis associated with membrane glycosylation remodeling during heart regeneration. Importantly, we establish the N- and O-linked glycan structural repertoire of the regenerating zebrafish heart, and link alterations in both sialylation and high mannose structures across the phases of regeneration. Our results show that metabolic reprogramming and glycan structural remodeling are potential drivers of tissue regeneration after cardiac injury, providing the biological rationale to develop novel therapeutics to elicit heart regeneration in mammals.

Transcriptomic and proteomic analyses reveal that glycosylation and carbohydrate metabolism are central processes in heart regeneration in zebrafish, including a shift from OXPHOS to glycolysis seven days after injury.

Details

Title
Metabolic reprogramming and membrane glycan remodeling as potential drivers of zebrafish heart regeneration
Author
Spelat, Renza 1   VIAFID ORCID Logo  ; Ferro, Federico 2   VIAFID ORCID Logo  ; Contessotto, Paolo 3 ; Aljaabary, Amal 4   VIAFID ORCID Logo  ; Martin-Saldaña, Sergio 4   VIAFID ORCID Logo  ; Jin, Chunsheng 5   VIAFID ORCID Logo  ; Karlsson, Niclas G. 5   VIAFID ORCID Logo  ; Grealy, Maura 6 ; Hilscher, Markus M. 7   VIAFID ORCID Logo  ; Magni, Fulvio 8 ; Chinello, Clizia 8 ; Kilcoyne, Michelle 9   VIAFID ORCID Logo  ; Pandit, Abhay 10   VIAFID ORCID Logo 

 University of Galway, CÚRAM, SFI Research Centre for Medical Devices, Galway, Ireland; International School for Advanced Studies (SISSA), Neurobiology Sector, Trieste, Italy (GRID:grid.5970.b) (ISNI:0000 0004 1762 9868) 
 University of Galway, CÚRAM, SFI Research Centre for Medical Devices, Galway, Ireland (GRID:grid.5970.b); University of Trieste, Department of Medical Surgery and Health Science, Trieste, Italy (GRID:grid.5133.4) (ISNI:0000 0001 1941 4308) 
 University of Galway, CÚRAM, SFI Research Centre for Medical Devices, Galway, Ireland (GRID:grid.5133.4); University of Padova, Department of Molecular Medicine, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470) 
 University of Galway, CÚRAM, SFI Research Centre for Medical Devices, Galway, Ireland (GRID:grid.5608.b) 
 University of Gothenburg, Department of Medical Biochemistry, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582) 
 University of Galway, Pharmacology and Therapeutics, School of Medicine, Galway, Ireland (GRID:grid.8761.8) 
 Stockholm University, Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm, Sweden (GRID:grid.10548.38) (ISNI:0000 0004 1936 9377) 
 University of Milano-Bicocca, Clinical Proteomics and Metabolomics Unit, School of Medicine and Surgery, Vedano al Lambro, Italy (GRID:grid.7563.7) (ISNI:0000 0001 2174 1754) 
 University of Galway, CÚRAM, SFI Research Centre for Medical Devices, Galway, Ireland (GRID:grid.7563.7); University of Galway, Carbohydrate Signalling Group, Microbiology, School of Natural Sciences, Galway, Ireland (GRID:grid.7563.7) 
10  University of Galway, CÚRAM, SFI Research Centre for Medical Devices, Galway, Ireland (GRID:grid.7563.7) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2753456349
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.